0 items USD 0.00Search
Your search for "mp advisors prioritizing generic drug development pipeline top fifty opportunities" gave back 1463934 results.
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
February 2017
Price: USD 3,600.00
“Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Cervical Intraepithelial Neoplasia (CIN) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,000.00
Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The global Type 2...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
The global 5-Ribosyluracil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Chemotherapy-Induced Nausea and Vomiting Drugs market size is expected to reach US$ 3044.6 million by 2029, growing at a CAGR of 2.5% from...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,000.00
Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
February 2020
Price: USD 175.00
Bacterial Conjunctivitis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2020
Price: USD 2,000.00
Metro Inc - Strategy, SWOT and Corporate Finance Report Summary Metro Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive...
Catalog:
MarketLine
April 2022
Price: USD 175.00
The global 5-Ribosyl Uracil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Pancreatitis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis...
Catalog:
Global Markets Direct
March 2018
Price: USD 2,000.00
The “Chemotherapy-Induced Nausea and Vomiting Drugs Industry Forecast” looks at past sales and reviews total world Chemotherapy-Induced Nausea and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
